reviewDrug Discovery TodayJun 11, 2010Closed access

What made sesquiterpene lactones reach cancer clinical trials?

AGAkram GhantousHGHala Gali‐MuhtasibHVHeikki VuorelaNANajat A. SalibaNDNadine Darwiche

American University of Beirut · University of Helsinki

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

614
total citations
FWCI
12.85
Percentile
100%
References
72
Citations per year

Authors

5

Topics & keywords

Topics
Keywords
  • Parthenolide
  • Sesquiterpene
  • Thapsigargin
  • Sesquiterpene lactone
  • Cancer
  • Artemisinin
  • Lipophilicity
  • Clinical trial
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding